DD292380A5 - Verwendung von furosemid - Google Patents

Verwendung von furosemid Download PDF

Info

Publication number
DD292380A5
DD292380A5 DD90338445A DD33844590A DD292380A5 DD 292380 A5 DD292380 A5 DD 292380A5 DD 90338445 A DD90338445 A DD 90338445A DD 33844590 A DD33844590 A DD 33844590A DD 292380 A5 DD292380 A5 DD 292380A5
Authority
DD
German Democratic Republic
Prior art keywords
nasal
furosemide
placebo
allergen
treatment
Prior art date
Application number
DD90338445A
Other languages
German (de)
English (en)
Inventor
Sebastiano Bianco
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD292380A5 publication Critical patent/DD292380A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Steroid Compounds (AREA)
DD90338445A 1989-03-08 1990-03-06 Verwendung von furosemid DD292380A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3907414A DE3907414A1 (de) 1989-03-08 1989-03-08 Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen

Publications (1)

Publication Number Publication Date
DD292380A5 true DD292380A5 (de) 1991-08-01

Family

ID=6375791

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90338445A DD292380A5 (de) 1989-03-08 1990-03-06 Verwendung von furosemid

Country Status (18)

Country Link
US (1) US5392767A (no)
EP (1) EP0386700B1 (no)
JP (1) JPH02279625A (no)
KR (1) KR900013955A (no)
CN (1) CN1045350A (no)
AT (1) ATE82853T1 (no)
AU (1) AU623502B2 (no)
CA (1) CA2011680A1 (no)
DD (1) DD292380A5 (no)
DE (2) DE3907414A1 (no)
DK (1) DK0386700T3 (no)
ES (1) ES2052998T3 (no)
GR (1) GR3007175T3 (no)
HU (1) HU205852B (no)
IE (1) IE900811L (no)
IL (1) IL93663A (no)
NO (1) NO901078L (no)
ZA (1) ZA901747B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
DE4023086A1 (de) * 1990-07-20 1992-01-23 Hoechst Ag Methode zur behandlung von allergischer konjunktivitis
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
WO1999016417A1 (en) 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US7231919B2 (en) 2001-09-28 2007-06-19 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US8168674B1 (en) * 2002-02-22 2012-05-01 Microdose Therapeutx, Inc. Method for treating bronchial diseases
AU2003249623A1 (en) * 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
EP1673123A2 (en) * 2003-09-05 2006-06-28 Kurve Technology, Inc. Integrated nebulizer and particle dispersing chamber for delivery of medicament
WO2005023334A2 (en) * 2003-09-05 2005-03-17 Kurve Technology, Inc. Nasal adapter for the base of the nose
WO2008028092A2 (en) 2006-08-30 2008-03-06 Kurve Technology, Inc. Aerosol generating and delivery device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3500M (fr) * 1964-06-15 1965-08-23 Fo We Forschungs Und Verwertun Nouveau médicament destiné au traitement des rhinites.
NZ209900A (en) * 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤

Also Published As

Publication number Publication date
CN1045350A (zh) 1990-09-19
CA2011680A1 (en) 1990-09-08
EP0386700A1 (de) 1990-09-12
HU901321D0 (en) 1990-05-28
JPH02279625A (ja) 1990-11-15
AU5075090A (en) 1990-10-11
NO901078D0 (no) 1990-03-07
DE3907414A1 (de) 1990-09-13
US5392767A (en) 1995-02-28
HUT52953A (en) 1990-09-28
AU623502B2 (en) 1992-05-14
DE59000518D1 (de) 1993-01-14
ES2052998T3 (es) 1994-07-16
NO901078L (no) 1990-09-10
IE900811L (en) 1990-09-08
IL93663A (en) 1994-11-11
KR900013955A (ko) 1990-10-22
IL93663A0 (en) 1990-12-23
ATE82853T1 (de) 1992-12-15
EP0386700B1 (de) 1992-12-02
ZA901747B (en) 1990-11-28
GR3007175T3 (no) 1993-07-30
HU205852B (en) 1992-07-28
DK0386700T3 (da) 1993-03-01

Similar Documents

Publication Publication Date Title
DD292380A5 (de) Verwendung von furosemid
DE69738000T2 (de) Neue Arzneiformulierung enthaltend Budesonide
DE60103527T2 (de) Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1121112B1 (de) Lagerfähiges wirkstoffkonzentrat mit formoterol
DE60026855T2 (de) Synergistische kombination von roflumilast und salmeterol
DE60209511T2 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
DE69333626T2 (de) Verwendung von Adamantan Derivaten zur Herstellung eines Medikaments zur GLAUKOMBEHANDLUNG
DE60002885T2 (de) Wässrige formulierung zur nasalen verabreichung
CH693763A5 (de) Verwendung eines Antibiotikums zur Herstellung eines Medikamentes zur Behandlung von schwerer chronischer Bronchitis (Bronchiektase).
DE4304893A1 (no)
DE2918799A1 (de) Ophthalmische loesung
EP1673074B1 (de) Flüssige zubereitung enthaltend tobramycin
DE60017175T2 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
EP2766008A1 (de) Zusammensetzung für die nasale applikation mit verbesserter stabilität
DE69636393T2 (de) Montirelin zur verhinderung der schlafapnoe
DE10136404A1 (de) Arzneiformulierung zur topischen Anwendung für die Therapie und Prophylaxe von Hyperhidrosis
EP0240907A2 (de) Verwendung von trans-4-[(2-Amino-3,5-dibrom-benzyl)-amino]cyclohexanol
Lüscher Die Alkalireserve des Blutes bei behinderter Nasenatmung und bei Tonsillenhyperplasie
EP2581082B1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus
DE602004007304T2 (de) Verwendung von N2O zur Behandlung von postischemischen cerebralen zellulären Beschädigungen
WO2017129457A1 (de) Pharmazeutische zubereitung und deren verwendung bei viralen, entzündlichen erkrankungen der oberen atemwege
DE60202299T2 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
DE4339144A1 (de) Topische, pharmazeutische Zusammensetzung für die Behandlung von Atmungsallergien
EP0467369A2 (de) Verwendung von Furosemid zur Behandlung von allergischer Konjunktivitis
Welte Noninvasive ventilation in the intensive care unit—Is it still negligible?

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee